MEASLES EPIDEMICS IN TURKEY AND DEVELOPING COUNTRIES: REVIEW OF THE LITERATURE |
||
Vaccination with an
attenuated live virus vaccine has proven to induce protective immunity
in seronegative individuals, and even low titers of neutralizing antibodies
seem to be protective. In developing countries with a high level of
infection, infants below the age of 12 months are at high risk for MV
infection. In this age group passively transferred maternal immunoglobulins
(Ig) pose a problem because declining maternal antibodies interfere
with vaccine-induced seroconversion but do not protect against infection
with wild-type MV (2-5). The World Health Organization (WHO) has advocated that outbreak immunization only be undertaken in areas with either high routine immunization coverage and the capacity to respond immediately to epidemics, or where there is overwhelming political pressure to intervene (6-8). In Turkey, the children are vaccinated againts measles at nine months of age routinely. The goal numbered twenty-five of The National Health Politics Document published by The Ministry of Health in March 1993 was nationwide eradication of measles untill 2005 (9), measles epidemics are still seen in our country causing hundreds of children deaths. In this study, it was aimed to evaluate the measles morbidity and mortality rates of Turkey during 1970-2001 and extent of global measles outbreaks. |
Material and Methods |
|